-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
March 01, 2013 - ...................................................................................... 19
Appendix C. … Appendix C shows the
questionnaire matrix used.
2.4 Check for qualitative and quantitative signals … Campbell L, Chen C, Bhagat SS, et al. … 16
Appendices
Appendix A: Search Methodology
Appendix B: Evidence Tables
Appendix C: … No
increased incidence
of malignancy, TB
reactivation or
hepatitis was found.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
March 01, 2013 - ...................................................................................... 19
Appendix C. … Appendix C shows the
questionnaire matrix used.
2.4 Check for qualitative and quantitative signals … Campbell L, Chen C, Bhagat SS, et al. … 16
Appendices
Appendix A: Search Methodology
Appendix B: Evidence Tables
Appendix C: … No
increased incidence
of malignancy, TB
reactivation or
hepatitis was found.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary44/sexually-transmitted-infections-behavioral-counseling-2008
October 15, 2008 - Exclusion Criteria
Clinical conditions
Sexual transmission of bacteria or virus (e.g., HIV, hepatitis … B and C, herpes simplex virus, human papillomavirus, chlamydia, gonorrhea, syphilis, and trichomonas … [PMID: 15249566]
Bolu OO, Lindsey C, Kamb ML, Kent C, Zenilman J, Douglas JM, et al. … [PMID: 11940275]
Proude EM, D'Este C, Ward JE. … [PMID: 9722807]
Herbst JH, Beeker C, Mathew A, McNally T, Passin WF, Kay LS, et al.
-
www.ahrq.gov/patient-safety/reports/advances-new-directions/index.html
July 01, 2022 - Risk Assessment
Risk-Based Patient Safety Metrics ( PDF , 614 KB )
Matthew C. … Creating Safety in the Testing Process in Primary Care Offices ( PDF , 414 KB )
Nancy C.
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/evidence-based-reports/nutrtp2.pdf
March 01, 2009 - systematic reviews into processes associated with the
derivation of nutrient intake reference values; c) … Vitamin C, vitamin E, selenium, and
carotenoids. National Academy of Science; 2000. … (16) Counsell C. … (20) Kjaergard LL, Villumsen J, Gluud C. … (23) Balk EM, Bonis PA, Moskowitz H, Schmid CH, Ioannidis JP, Wang C et al.
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2019.jsp
January 01, 2019 - STATE-SPECIFIC RESTRICTIONS
Table C.1. … Table C.1. … Mycoses
10,755
27.56
28.10
2.0
5: HIV infection
7,495
26.99
27.66
2.5
6: Hepatitis … including parasitic
4,117
13.46
14.09
4.7
9: Sexually transmitted infections (not HIV or hepatitis … Andrews R, Kassed C, Nagamine M.
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2020.jsp
January 01, 2020 - STATE-SPECIFIC RESTRICTIONS
Table C.1. … Table C.1. … Mycoses
10,755
27.56
28.10
2.0
5: HIV infection
7,495
26.99
27.66
2.5
6: Hepatitis … including parasitic
4,117
13.46
14.09
4.7
9: Sexually transmitted infections (not HIV or hepatitis … Andrews R, Kassed C, Nagamine M.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-in-pregnancy-screening-2009
May 15, 2009 - screening for other sexually transmitted diseases in pregnancy, including gonorrhea, chlamydial infection, hepatitis … [PMID: 15306757]
Wolff T, Shelton E, Sessions C, Miller T.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions
October 20, 2016 - for adolescents)
Alcohol Use Disorders Identification Test (AUDIT), its abbreviated version (AUDIT-C) … health symptoms/disorders; alcohol-related liver problems, including fatty liver disease, alcoholic hepatitis
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan18/drug-use-illicit-primary-care-interventions-for-children-and-adolescents-march-2014
May 15, 2013 - including, but not limited to: mental health disorders, sexually transmitted infection/HIV transmission, hepatitis … B or C transmission, unintended pregnancies/pregnancy complications, respiratory infections, cardiovascular
-
integrationacademy.ahrq.gov/products/playbooks/opioid-use-disorder/implement-mat-for-oud/screening-and-diagnosis
January 01, 2018 - of opioid use disorder; Other relevant medical conditions (i.e., pregnancy testing, liver function, hepatitis … B and C testing, HIV testing); and Other relevant psychiatric disorders, including depression and specifically
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - ...................................................................................... 19
Appendix C. … Gaujoux-Viala C, Giampietro C, Gaujoux
T, et al. Scleritis: a paradoxical effect of
etanercept? … Sandborg C, Mellins ED. A new era in
the treatment of systemic juvenile idiopathic
arthritis. … C-reactive
protein and ferritin normalized
within this interval in >80%. … AE’s included
bacterial infection in 2 patients
and hepatitis in 1
Key Question 2: In children with
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - ...................................................................................... 19
Appendix C. … Gaujoux-Viala C, Giampietro C, Gaujoux
T, et al. Scleritis: a paradoxical effect of
etanercept? … Sandborg C, Mellins ED. A new era in
the treatment of systemic juvenile idiopathic
arthritis. … C-reactive
protein and ferritin normalized
within this interval in >80%. … AE’s included
bacterial infection in 2 patients
and hepatitis in 1
Key Question 2: In children with
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-fullreport.pdf
February 01, 2018 - Measure Number
0228
1.C. … percent) than costs for treating other conditions between 1997 and
2005 (Rivers, Ahrens, 2008).
3.C. … c. Care Setting – other – please specify: Yes; emergency department.
d. … contain questions related to the special health care needs of
individuals using the ED.
15
7.C. … Not applicable.
11.C.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary38/obesity-in-adults-screening-and-management-2012
October 15, 2011 - Egger M, Davey Smith G, Schneider M, Minder C. … Jeffery RW, Wing RR, Thorson C, Burton LR, Raether C, Harvey J, et al. … Berne C; Orlistat Swedish Type 2 Diabetes Study Group. … Hauptman J, Lucas C, Boldrin MN, Collins H, Segal KR. … Kirk EP, Jacobsen DJ, Gibson C, Hill JO, Donnelly JE.
-
hcup-us.ahrq.gov/reports/statbriefs/sb244-Opioid-Inpatient-Stays-ED-Visits-Older-Adults.pdf
February 01, 2018 - Weiss, Ph.D., Kevin C. Heslin, Ph.D.,
Marguerite L. … +
overall
65–74 75–84 85+ 65+
overall
65+
overall
65–74 75–84 85+ 65+
overall
Pe
rc
en
ta
ge
C … 127
Asthma CCS 128
Chronic kidney disease CCS 156, 158
Human immunodeficiency virus (HIV) CCS 5
Hepatitis … u=https-3A__claritas360.claritas.com_mybestsegments_&d=DwMFAg&c=jf_iaSHvJObTbx-siA1ZOg&r=2qQwVBn6hVQgR7RNjEA4Tc2Yt-lUl674IM-sBUsuioI … Weiss, Ph.D., Kevin C. Heslin, Ph.D.,
Marguerite L.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/2DGd8AvVMTJwP3ttrPcnLL
February 25, 2020 - Vital Hepatitis,
STD, and TB. Trends in the prevalence of tobacco
use: national YRBS: 1991-2017. … Selph S, Patnode C, Bailey S, et al Primary Care
Relevant Interventions for Tobacco and Nicotine Use … Selph S, Patnode C, Bailey SR, Pappas M, Stoner
R, Chou R. … Hiemstra M, Ringlever L, Otten R, van Schayck
OC, Jackson C, Engels RC. … Jackson C, Dickinson D.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-abuse-screening-1996
January 01, 1996 - complications from injecting contaminated materials (e.g., human immunodeficiency virus [HIV] infection, hepatitis … Colmorgen GHC, Johnson C, Zazzarino MA, et al. … Chasnoff IJ, Griffith DR, Freier C, Murray J. … Wickizer T, Maynard C, Atherly A, et al. … Power R, Hartnoll R, Chalmers C.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
January 15, 2016 - Research Review Citation: Chinnadurai S, Snyder K, Sathe N, Fonnesbeck C, Morad A,
Likis FE, Surawicz … T, Ness G, Ficzere C, McPheeters ML. … Peer reviewer #1 Methods Fig C- Final Health Outcomes: is there a causation for
problems with thyroid … Timolol – 64% clearance
c. intralesionalTriamcinolone – 54%
d.
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
October 01, 2017 - Patient is likely to have adverse reactions to statins.
c. … abnormal blood cholesterol, represented HDL-C < 40 mg/dL or LDL-C > 130 mg/dL
Grade B and C
"Diabetes … "
Type 1 and Type 2 Diabetes
Grade B and C
"Hypertension"
high blood pressure
Grade B and C
" … the work group, not all liver conditions clearly exclude a recommendation for statin therapy (e.g., Hepatitis … B and C).